Introduction
Review of Pathophysiology of Type 2 Diabetes
"Syndrome X" (Insulin Resistance Syndrome)
Insulin Resistance Syndrome Interventions
References
Introduction
- The Diabetes Epidemic
- 15.7 million Americans have diabetes
- Approximately 6% of the population
- One-third are undiagnosed, therefor, untreated
- Approximately 100 million people have diabetes worldwide
- 5-10% have type 1 diabetes
- 90-95% have type 2 diabetes
- Diabetes on the rise
- Not due to changes in the disease or its treatment
- Associated with older age, lack of physical exercise, and obesity
- Our population is older, less active, and more overweight
Review of Pathophysiology of Type 2 Diabetes
- Insulin Resistance
- Defect in muscle and fat cell utilization of insulin
- Precedes the manifestation of type 2 diabetes
- Pancreas responds by producing more insulin to overdrive the cells
- Results in hyperinsulinemia
- Diabetes results when there is a relative insulin deficiency
- Hyperinsulinemia
- Stimulates fat storage
- Increases appetite
- Increase in sodium reabsorption in the kidneys
- Increase in vascular smooth muscle proliferation
- Decrease in fibrinolysis
- Increased hepatic glucose output
- Increased glycogen production and gluconeogenesis
- Causes fasting hyperglycemia
- Caused by hepatic insulin resistance
- Glucose Toxicity
- High glucose levels cause impaired cell function/damage
- >115 mg/dl is threshold for pancreas
- >180 mg/dl is threshold for nerve cells
- Eventually leads to hypoinsulinemia and other complications
- Markers of elevated plasma insulin levels
- Increase in serum triglycerides
- Decrease in HDL cholesterol
"Syndrome X" (Insulin Resistance Syndrome)
- Hyperinsulinemia
- Hypertension
- Dyslipidemia
- low HDL
- high Triglycerides
- smaller, denser LDL
- Impaired Glucose Tolerance
- Visceral Adiposity
- Increased PAI-1 (plasminogen activator inhibitor-1)
- Hyperuricemia
- PCOS (polycystic ovarian syndrome)
- hyperandrogenism
- chronic anovulation
- polycystic ovaries
- Increased risk of CHD
Insulin Resistance Syndrome Interventions
- Weight loss
- Control lipids
- Reduce CHD risk factors
- Decrease insulin resistance
- Daily aspirin
Last updated: December 1, 2000
Use of this section indicates you agree to the Terms of Use.
Copyright 1994-2003 NP Central
|








|
|